SCHEMBL19494898

SCHEMBL19494898

CNc1sc(Sc2ccc(F)cc2)cc1C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 4/20 0.45
▸ IKBKB O14920 3/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ EIF2AK2 P19525 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ CFTR P13569 4/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ MAPK8 P45983 1/20 0.36
▸ PTGS2 P35354 1/20 0.35
▸ MTNR1A P48039 1/20 0.35
▸ MTNR1B P49286 1/20 0.35
▸ PIK3CA P42336 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494413 0.84 IKBKB (0.46) JAK2IKBKBMEN1KMT2AEIF2AK2
SCHEMBL19494924 0.83 CHEK1 (0.51) JAK2MAPK8
SCHEMBL19494396 0.80 CFTR (0.43) JAK2IKBKBMEN1KMT2AEIF2AK2
SCHEMBL19494442 0.79 MEN1 (0.42) JAK2IKBKBMEN1KMT2AEIF2AK2
SCHEMBL19494938 0.78 MEN1 (0.41) JAK2IKBKBMEN1KMT2AEIF2AK2
SCHEMBL19494459 0.77 PIK3CB (0.41) JAK2MEN1KMT2AKDM4EALDH1A1
SCHEMBL19494343 0.77 IKBKB (0.39) JAK2IKBKBMEN1KMT2AEIF2AK2
SCHEMBL19494470 0.77 CHEK1 (0.38) JAK2IKBKBMEN1KMT2AEIF2AK2
SCHEMBL19494512 0.76 IKBKB (0.41) JAK2IKBKBMEN1KMT2AEIF2AK2
SCHEMBL19494654 0.75 NNMT (0.35) JAK2IKBKBMEN1KMT2AEIF2AK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback